PARASAL SODIUM Drug Patent Profile
Which patents cover Parasal Sodium, and when can generic versions of Parasal Sodium launch?
Parasal Sodium is a drug marketed by Panray and is included in one NDA.
The generic ingredient in PARASAL SODIUM is aminosalicylate sodium. There is one drug master file entry for this compound. Additional details are available on the aminosalicylate sodium profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PARASAL SODIUM?
- What are the global sales for PARASAL SODIUM?
- What is Average Wholesale Price for PARASAL SODIUM?
Summary for PARASAL SODIUM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 3,645 |
| DailyMed Link: | PARASAL SODIUM at DailyMed |
US Patents and Regulatory Information for PARASAL SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Panray | PARASAL SODIUM | aminosalicylate sodium | TABLET;ORAL | 006811-011 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Panray | PARASAL SODIUM | aminosalicylate sodium | TABLET;ORAL | 006811-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
